Genotypic Determination of Extended Spectrum β-Lactamases and Carbapenemase Production in Clinical Isolates of Klebsiella pneumoniae in Southwest Nigeria

Introduction: Klebsiella pneumoniae is a major pathogen implicated in healthcare-associated infections. Extended-spectrum β-lactamase (ESBL) and carbapenemase-producing K. pneumoniae isolates are a public health concern. This study investigated the existence of some ESBL and carbapenemase genes among clinical isolates of K. pneumoniae in Southwest Nigeria and additionally determined their circulating clones. Materials and Methods: Various clinical samples from 420 patients from seven tertiary hospitals within Southwestern Nigeria were processed between February 2018 and July 2019. These samples were cultured on blood agar and MacConkey agar, and the isolated bacteria were identified by Microbact GNB 12E. All K. pneumoniae were confirmed by polymerase chain reaction (PCR) using the 16s rRNA gene. Antibiotic susceptibility testing (AST) was done on these isolates, and the PCR was used to evaluate the common ESBL-encoding genes and carbapenem resistance genes. Genotyping was performed using multi-locus sequencing typing (MLST). Results: The overall prevalence of K. pneumoniae in Southwestern Nigeria was 30.5%. The AST revealed high resistance rates to tetracyclines (67.2%), oxacillin (61.7%), ampicillin (60.2%), ciprofloxacin (58.6%), chloramphenicol (56.3%), and lowest resistance to meropenem (43.0%). All isolates were susceptible to polymyxin B. The most prevalent ESBL gene was the TEM gene (47.7%), followed by CTX-M (43.8%), SHV (39.8%), OXA (27.3%), CTX-M-15 (19.5%), CTX-M-2 (11.1%), and CTX-M-9 (10.9%). Among the carbapenemase genes studied, the VIM gene (43.0%) was most detected, followed by OXA-48 (28.9%), IMP (22.7%), NDM (17.2%), KPC (13.3%), CMY (11.7%), and FOX (9.4%). GIM and SPM genes were not detected. MLST identified six different sequence types (STs) in this study. The most dominant ST was ST307 (50%, 5/10), while ST258, ST11, ST147, ST15, and ST321 had (10%, 1/10) each. Conclusion: High antimicrobial resistance in K. pneumoniae is a clear and present danger for managing infections in Nigeria. Additionally, the dominance of a successful international ST307 clone highlights the importance of ensuring that genomic surveillance remains a priority in the hospital environment in Nigeria.

[1]  I. Okeke,et al.  Clones and Clusters of Antimicrobial-Resistant Klebsiella From Southwestern Nigeria , 2021, bioRxiv.

[2]  Ahmed M. Abdel Tawab,et al.  Emergence of Colistin and Carbapenem Resistance in Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Isolated from Chickens and Humans in Egypt , 2021, Biology.

[3]  M. Adikwu,et al.  Metallo-β-lactamase and AmpC genes in Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolates from abattoir and poultry origin in Nigeria , 2021, BMC Microbiology.

[4]  Mathias W Pletz,et al.  The Emergence of Klebsiella pneumoniae with Reduced Susceptibility against Third Generation Cephalosporins and Carbapenems in Lagos Hospitals, Nigeria , 2021, Antibiotics.

[5]  S. Andrews,et al.  Analysis of Antibiotic Resistance and Virulence Traits (Genetic and Phenotypic) in Klebsiella pneumoniae Clinical Isolates from Pakistan: Identification of Significant Levels of Carbapenem and Colistin Resistance , 2021, Infection and drug resistance.

[6]  M. Tawfick,et al.  Phenotypic and Genotypic Features of Klebsiella pneumoniae Harboring Carbapenemases in Egypt: OXA-48-Like Carbapenemases as an Investigated Model , 2020, Antibiotics.

[7]  J. Rolain,et al.  Phenotypic and genotypic characterization of clinical carbapenem-resistant Enterobacteriaceae isolates from Sokoto, northwest Nigeria , 2020, New microbes and new infections.

[8]  Igunma Agbons Jeremiah,et al.  Genotypic Determination of Carbapenamase Gene Production in Clinical Isolates of Klebsiella pneumoniae in the University of Port-Harcourt Teaching Hospital , 2020 .

[9]  M. Banjara,et al.  Detection of OXA-48 Gene in Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae from Urine Samples , 2020, Infection and drug resistance.

[10]  J. Osei Sekyere,et al.  Epigenomics, genomics, resistome, mobilome, virulome and evolutionary phylogenomics of carbapenem-resistant Klebsiella pneumoniae clinical strains , 2020, medRxiv.

[11]  H. Goudarzi,et al.  Prevalence and Mechanisms of Carbapenem Resistance in Klebsiella pneumoniae and Escherichia coli: A Systematic Review and Meta-Analysis of Cross-Sectional Studies from Iran. , 2020, Microbial drug resistance.

[12]  Xiyan Xu,et al.  Diversity and frequency of resistance and virulence genes in blaKPC and blaNDM co-producing Klebsiella pneumoniae strains from China , 2019, Infection and drug resistance.

[13]  G. Adeshina,et al.  Incidence of carbapenemase production among antibiotic resistant Klebsiella isolates in Zaria, Nigeria , 2019, Nigerian Journal of Biotechnology.

[14]  M. Wootton,et al.  Rapid detection of IMP, NDM, VIM, KPC and OXA-48-like carbapenemases from Enterobacteriales and Gram-negative non-fermenter bacteria by real-time PCR and melt-curve analysis , 2019, European Journal of Clinical Microbiology & Infectious Diseases.

[15]  J. M. Vargas,et al.  Virulence factors and clinical patterns of multiple-clone hypermucoviscous KPC-2 producing K. pneumoniae , 2019, Heliyon.

[16]  A. Duarte,et al.  Community- and Hospital-Acquired Klebsiella pneumoniae Urinary Tract Infections in Portugal: Virulence and Antibiotic Resistance , 2019, Microorganisms.

[17]  A. Maleki,et al.  Phenotypic and Genotypic Characterization of ESBL-, AmpC-, and Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli Isolates , 2019, Medical Principles and Practice.

[18]  A. Abdollahi,et al.  Molecular Epidemiology and Drug Resistance Pattern of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Iran. , 2019, Microbial drug resistance.

[19]  J. Silva-Sánchez,et al.  The successful containment of a hospital outbreak caused by NDM-1-producing Klebsiella pneumoniae ST307 using active surveillance , 2019, PloS one.

[20]  E. D. da Silva,et al.  High Prevalence of Multidrug-Resistant Klebsiella pneumoniae Harboring Several Virulence and β-Lactamase Encoding Genes in a Brazilian Intensive Care Unit , 2019, Front. Microbiol..

[21]  A. Sumi,et al.  Prevalence and Molecular Epidemiology of Clinical Isolates of Escherichia coli and Klebsiella pneumoniae Harboring Extended-Spectrum Beta-Lactamase and Carbapenemase Genes in Bangladesh. , 2018, Microbial drug resistance.

[22]  O. Olowe,et al.  Healthcare associated infections caused by plasmid-encoded blaKPC and blaNDM strains of Klebsiella pneumoniae in Ibadan, Nigeria , 2018, Pan African Journal of Life Sciences.

[23]  H. Samadi kafil,et al.  The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections , 2018, Infection and drug resistance.

[24]  M. Doudi,et al.  Evaluation of Modified Hodge Test as a Non-molecular Assay for Accurate Detection of KPC-producing Klebsiella pneumoniae , 2018, Polish journal of microbiology.

[25]  Prateek Shrivastava,et al.  World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics , 2018 .

[26]  K. Holt,et al.  Antimicrobial-Resistant Klebsiella pneumoniae Carriage and Infection in Specialized Geriatric Care Wards Linked to Acquisition in the Referring Hospital , 2017, bioRxiv.

[27]  M. Uzoamaka,et al.  Bacterial Etiology of Lower Respiratory Tract Infections and Their Antimicrobial Susceptibility , 2017, The American journal of the medical sciences.

[28]  J. Parkhill,et al.  Evolution and Epidemiology of Multidrug-Resistant Klebsiella pneumoniae in the United Kingdom and Ireland , 2017, mBio.

[29]  L. Obi,et al.  Molecular Characteristics and Antibiotic Resistance Profiles of Klebsiella Isolates in Mthatha, Eastern Cape Province, South Africa , 2017, International journal of microbiology.

[30]  Y. Ibrahim,et al.  Phenotypic Detection of Extended Spectrum Beta lactamase and Carbapenemase Co-producing Clinical Isolates from Two Tertiary Hospitals in Kano, North West Nigeria , 2017, Ethiopian journal of health sciences.

[31]  Yonghong Xiao,et al.  High Prevalence of ESBL-Producing Klebsiella pneumoniae Causing Community-Onset Infections in China , 2016, Frontiers in microbiology.

[32]  Francesco Comandatore,et al.  Tracking Nosocomial Klebsiella pneumoniae Infections and Outbreaks by Whole-Genome Analysis: Small-Scale Italian Scenario within a Single Hospital , 2015, Journal of Clinical Microbiology.

[33]  R. Saranathan,et al.  Simultaneous gut colonisation and infection by ESBL-producing Escherichia coli in hospitalised patients. , 2015, The Australasian medical journal.

[34]  G. Rossolini.  Extensively drug‐resistant carbapenemase‐producing Enterobacteriaceae: an emerging challenge for clinicians and healthcare systems , 2015, Journal of internal medicine.

[35]  E. Abdala,et al.  Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[36]  R. Bonnet,et al.  First characterization of CTX-M-15 and DHA-1 β- lactamases among clinical isolates of Klebsiella pneumoniae in Laghouat Hospital, Algeria , 2014 .

[37]  Subhash Todi,et al.  Guidelines for prevention of hospital acquired infections , 2014, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[38]  F. Bwanga,et al.  Carbapenemase Genes among Multidrug Resistant Gram Negative Clinical Isolates from a Tertiary Hospital in Mwanza, Tanzania , 2014, BioMed research international.

[39]  Guiqing Wang,et al.  CTX-M β-Lactamase–producing Klebsiella pneumoniae in Suburban New York City, New York, USA , 2013, Emerging infectious diseases.

[40]  P. Srivastava,et al.  Prevalence and antibiogram of Extended Spectrum β-Lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. , 2013, Journal of clinical and diagnostic research : JCDR.

[41]  P. Nordmann,et al.  Multiplex PCR for detection of acquired carbapenemase genes. , 2011, Diagnostic microbiology and infectious disease.

[42]  F. Aarestrup,et al.  Emergence of Multidrug-Resistant Salmonella Concord Infections in Europe and the United States in Children Adopted From Ethiopia, 2003–2007 , 2009, The Pediatric infectious disease journal.

[43]  T. Van,et al.  Safety of raw meat and shellfish in Vietnam: an analysis of Escherichia coli isolations for antibiotic resistance and virulence genes. , 2008, International journal of food microbiology.

[44]  M. Castanheira,et al.  Rapid Detection and Identification of Metallo-β-Lactamase-Encoding Genes by Multiplex Real-Time PCR Assay and Melt Curve Analysis , 2006, Journal of Clinical Microbiology.

[45]  Sylvain Brisse,et al.  Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial Isolates , 2005, Journal of Clinical Microbiology.

[46]  K. Hopkins,et al.  blaCTX-M Genes in Clinical Salmonella Isolates Recovered from Humans in England and Wales from 1992 to 2003 , 2005, Antimicrobial Agents and Chemotherapy.

[47]  Ronald N. Jones,et al.  Molecular Characterization of a β-Lactamase Gene, blaGIM-1, Encoding a New Subclass of Metallo-β-Lactamase , 2004, Antimicrobial Agents and Chemotherapy.

[48]  P. Nordmann,et al.  Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae , 2004, Antimicrobial Agents and Chemotherapy.

[49]  María García,et al.  Detection of CMY-2, CTX-M-14, and SHV-12 β-Lactamases in Escherichia coli Fecal-Sample Isolates from Healthy Chickens , 2003, Antimicrobial Agents and Chemotherapy.

[50]  H. Shin,et al.  Imipenem-EDTA Disk Method for Differentiation of Metallo-β-Lactamase-Producing Clinical Isolates of Pseudomonas spp. and Acinetobacter spp , 2002, Journal of Clinical Microbiology.

[51]  N. Hanson,et al.  Detection of Plasmid-Mediated AmpC β-Lactamase Genes in Clinical Isolates by Using Multiplex PCR , 2002, Journal of Clinical Microbiology.

[52]  D. Egah,et al.  High Rates of Bacteria Isolates of Neonatal Sepsis with Multidrug Resistance Patterns in Jos , Nigeria , 2015 .

[53]  H. Zar,et al.  The spread of carbapenemase-producing bacteria in Africa: a systematic review. , 2015, The Journal of antimicrobial chemotherapy.

[54]  D. Hoban,et al.  Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. , 2010, Diagnostic microbiology and infectious disease.

[55]  Seungok Lee,et al.  Occurrence of extended-spectrum (beta)-lactamases and plasmid-mediated AmpC (beta)-lactamases among Korean isolates of Proteus mirabilis. , 2006, The Journal of antimicrobial chemotherapy.

[56]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .